Recent News
Elmiron Pigmentary Maculopathy Warning on Canadian Label. Why Not United States?
The manufacturers of Elmiron (pentosan polysulfate sodium) recently updated the drug’s Canadian label to warn of the potential for pigmentary maculopathy, a retinal disorder that can result in permanent vision loss. Yet the labeling for Elmiron sold in the United … Continue reading
Kidney Cancer Lawsuit Filed After Firefighting Foam Exposure
An Idaho man suffering from kidney cancer is pursuing a new lawsuit against the manufacturers of aqueous film-forming foams (AFFF), a type of firefighting foam widely used at military bases and civilian airports for decades. Kidney Cancer and Firefighting Foam … Continue reading
Zantac Lawsuits Move Forward, With Issuance of New Pretrial Orders
The federal multidistrict litigation established for all Zantac lawsuits stemming from recent drug recalls continues to move forward, with the issuance of two new pretrial orders in the U.S. District Court, Southern District of Florida. The first was issued on April … Continue reading
Firefighting Foam Lawsuit Claims PFAS Exposure Caused Lymphoma, Testicular Cancer
A former firefighter from Vermont has filed a new lawsuit alleging his Hodgkin’s lymphoma and testicular cancer were the direct result of exposure to the aqueous film-forming (AFF) firefighting foams he used on the job. Firefighting Foam Lawsuit Allegations According … Continue reading
Another Heartburn Drug Recalled for Cancer-Causing Impurity
Amneal Pharmaceuticals has announced a nationwide recall of Nizatidine Oral Solution over concerns the medication may contain Nitrosodimethylamine (NDMA) – a probable human carcinogen – above guidelines established by the U.S. Food & Drug Administration (FDA). Nizatidine is indicated to … Continue reading
FDA Priority Review of High-Risk Medical Devices Linked to More Recalls
A new study suggests that Class III medical devices (those considered high-risk) are more likely to be recalled if they come to market via the U.S. Food & Drug Administration’s (FDA) priority review program. FDA Medical Device Approval: Priority Review … Continue reading
Takeda Pharmaceuticals Hit with New Uloric Heart Attack Lawsuit
Takeda Pharmaceuticals is facing yet another lawsuit over Uloric, a gout drug allegedly linked to an increased risk of heart attack and cardiovascular death. Uloric Lawsuit Allegations This new case was filed in the U.S. District Court, Northern District of … Continue reading
Researchers Warn Elmiron Maculopathy Might be Misdiagnosed
Researchers are warning doctors to carefully review medical histories of patients experiencing vision loss and other eye problems, after finding that maculopathy associated with the bladder pain drug Elmiron is easily misdiagnosed. Elmiron Maculopathy Mistaken for Stargardt Disease Their paper, … Continue reading
Zantac Recall News: U.S. Defense Health Agency Issues Ranitidine Warning
The U.S. Defense Health Agency is warning military beneficiaries to stop taking name-brand Zantac and generic ranitidine products, amid concerns that the popular heartburn medications might contain high levels of N-nitrosodimethylamin (NDMA), a probable human carcinogen. Zantac Users Should Switch … Continue reading
Metformin Warning: Study Points to Toxicity with Coronavirus Treatments
Bernstein Liebhard is not currently pursuing lawsuits on this drug, but if you fill out our form, we will let you know if that changes. A new study suggests some potential coronavirus treatments may prove toxic when administered to patients … Continue reading
Follow Us
